STAR Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
201 Haskins Way Fl 5, South San Francisc...Phone Number
(888) 742-1338Website
www.star-therapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
3
1
1
1
About STAR Therapeutics
Star Therapeutics is a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions of patients who lack effective treatment options. The company's engine for innovation starts with identifying multiple rare diseases that share a common biology and then discovering novel therapeutics that can treat these diseases with a single therapy. Star consists of a family of companies, each focused on a specific area of biology with first-in-class therapies that each target multiple diseases. Star is backed by leading life sciences investors and located in South San Francisco.Explore more
STAR Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is STAR Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at STAR Therapeutics
Funding: Get notified immidiatlly once STAR Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on STAR Therapeutics recently announced quarterly report
Check out if STAR Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if STAR Therapeutics had a recent Job posting/layoffs
STAR Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if STAR Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when STAR Therapeutics launches new products
Recommended Actions
Find VP level buyers at STAR Therapeutics
Find more new buyers
Compare Similar Companies to STAR Therapeutics
Compare insights from companies similar to STAR Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
STAR Therapeutics
<$5M
11-50
Private
$340M
2018
Scott RobertsonChief Business Officer & Chief Financial Officer
Company Profile Activity
Activity Insights
STAR Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
STAR Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about STAR Therapeutics.
STAR Therapeutics financials insights
Gather financial insights about STAR Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series C
$90M
2025
Series D
$125M
Private Equity
$125M
STAR Therapeutics Tech Stack
A closer look at the technologies used by STAR Therapeutics
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Funding
New Hire
Executive Move
Event
Events
Left Company
Executive Move
STAR Therapeutics News & Media
Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VGA039 in von Willebrand disease (VWD). VGA039 is an investigational monoclonal antibody that targets Protein S to restore balance in blood clotting, as a universal hemostatic therapy for numerous bleeding disorders. It is potentially theStar Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today announced that it will present at the 43rd annual J.P. Morgan Healthcare Conference taking place on January 13-16, 2025 in San Francisco, CA. Adam Rosenthal, Ph.D., CEO and Founder of Star Therapeutics, is scheduled to present an overview of the company and its lead drug candidate, VGA039, a therapy for von Willebrand disease (VWD) anStar Therapeutics Presents Interim Clinical Data for VGA039 in Patients with Von Willebrand Disease (VWD) at ASH 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today announced interim clinical data from VIVID 2 (VGA039 Investigation in Von Willebrand Disease), a Phase 1 single ascending dose (SAD) study of VGA039 in Von Willebrand Disease (VWD) patients. VGA039 is an investigational monoclonal antibody that targets Protein S to restore balance in blood clotting, as a universal hemostatic therapy fStar Therapeutics Presents Clinical Data for VGA039, a Subcutaneous Therapy for the Treatment of Von Willebrand Disease (VWD)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today announced the presentation of clinical data from VIVID 1 (VGA039 Investigation in Von Willebrand Disease), a Phase 1 clinical study of VGA039 in healthy volunteers. VGA039 is designed to be a universal hemostatic therapy for numerous bleeding disorders and potentially the first subcutaneous therapy for von Willebrand disease (VWD). Th
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding STAR Therapeutics
Sign Up For FreeTo access detailed company insights
Star Therapeutics is a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions of patients who lack effective treatment options. The company's engine for innovation starts with identifying multiple rare diseases that share a common biology and then discovering novel therapeutics... Read More
